Topiramate as an Adjunctive Treatment for Refractory Partial Epilepsy in the Elderly

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of International Medical Research

• Publication date

  2011-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/147323001103900208PMID 21672344
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long‐term efficacy and tolerability of topiramate as add‐on therapy in refractory partial epilepsy: An observational study

  2009cited by this paper
• Topiramate in older patients with partial‐onset seizures: A pilot double‐blind, dose‐comparison study

  2008cited by this paper
• Increased propensity for calcium phosphate kidney stones with topiramate use

  2007cited by this paper
• Issues when treating epilepsy in the elderly

  2007cited by this paper
• Biochemical and Stone-Risk Profiles With Topiramate Treatment

  2007cited by this paper
• Stellenwert der niedrig dosierten Topiramat-Monotherapie von Epilepsien im Erwachsenenalter mit fokalen und generalisierten Anfällen

  2007cited by this paper
• Biochemical and stone-risk profiles with topiramate treatment.

  2006cited by this paper
• Issues when treating epilepsy in the elderly

  2005cited by this paper
• Experience with topiramate monotherapy in elderly patients with recent‐onset epilepsy

  2005cited by this paper
• Randomized dose‐controlled study of topiramate as first‐line therapy in epilepsy

  2005cited by this paper
• Understanding the burden of epilepsy in Latin America: a systematic review of its prevalence and incidence.

  2005cited by this paper
• The epidemiology of epilepsy revisited

  2003cited by this paper
• A pooled analysis of adjunctive topiramate in refractory partial epilepsy

  2003cited by this paper
• A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy

  2003cited by this paper
• Low‐dose topiramate in adults with treatment‐resistant partial‐onset seizures

  2002cited by this paper
• Epilepsy in elderly people.

  2000cited by this paper
• An Overview of the Preclinical Aspects of Topiramate: Pharmacology, Pharmacokinetics, and Mechanism of Action

  2000cited by this paper
• Topiramate in the Long‐Term Management of Refractory Epilepsy

  2000cited by this paper
• A Double‐Blind, Placebo‐Controlled Study of Topiramate in Adult Patients with Refractory Partial Epilepsy

  2000cited by this paper
• Topiramate as Add‐On Therapy: Pooled Analysis of Randomized Controlled Trials in Adults

  2000cited by this paper
• Topiramate in Medically Intractable Partial Epilepsies: Double‐Blind Placebo‐Controlled Randomized Parallel Group Trial

  1999cited by this paper
• Epidemiology and Drug Treatment of Epilepsy in Elderly People

  1999cited by this paper
• Double‐Blind, Placebo‐Controlled Trial of Topiramate as Add‐on Therapy in Patients with Refractory Partial Seizures

  1996cited by this paper
• Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy.

  1996cited by this paper
• Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages

  1996cited by this paper
• Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages

  1996cited by this paper
• Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy.

  1989cited by this paper

• Efficacy and safety of add‐on antiseizure medications for focal epilepsy: A network meta‐analysis

  2024cites this paper
• Scoping review of rational polytherapy in patients with drug‐resistant epilepsy

  2022cites this paper
• Management of epilepsy in older adults: A critical review by the ILAE Task Force on Epilepsy in the elderly

  2022cites this paper
• Topiramate add-on therapy for drug-resistant focal epilepsy.

  2019influential citation
• Felbamate add-on therapy for drug-resistant focal epilepsy.

  2019cites this paper
• Model-based sensitivity analysis for outcome reporting bias in the meta analysis of benefit and harm outcomes

  2019cites this paper
• Efficacy, safety, and tolerability of perampanel in Asian and non‐Asian patients with epilepsy

  2019cites this paper
• The medical treatment of epilepsy in the elderly: A systematic review and meta‐analysis

  2019cites this paper
• Advances with extended and controlled release formulations of antiepileptics in the elderly

  2018cites this paper
• Can the Impact of Topiramate on Memory Processes be Related to Its ‘Antialcoholic Activity’?—A Preclinical Study

  2018cites this paper
• Randomized controlled trials of antiepileptic drugs for the treatment of post-stroke seizures: A systematic review with network meta-analysis.

  2018cites this paper
• Evaluate the Efficacy and Safety of Anti‐Epileptic Medications for Partial Seizures of Epilepsy: A Network Meta‐Analysis

  2017cites this paper
• Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis

  2017cites this paper
• Comparison of impact on seizure frequency and epileptiform discharges of children with epilepsy from topiramate and phenobarbital.

  2016cites this paper
• Evaluation of the efficacy and safety of topiramate as adjunctive drug in the treatment of refractory partial seizures with Meta-analysis

  2014cites this paper
• Topiramate add-on for drug-resistant partial epilepsy.

  2014cites this paper
• A comparison of extracellular excitatory amino acids release inhibition of acute lamotrigine and topiramate treatment in the hippocampus of PTZ-kindled epileptic rats.

  2013cites this paper
• Topiramate and cognitive impairment: evidence and clinical implications

  2012cites this paper
• Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials.

  2011cites this paper